Purchase GM2 Labs USA Melanotan Peptide PT141

What is Bremelanotide PT-141

PT-141 Bremelanotide is the generic term for a new medication for use in treating sexual dysfunction in men (erectile dysfunction or impotence) as well as dysfunction in women (sexual arousal disorder). PT141 works to stimulate the melanocortin system triggering a cascade of effects starting with the hypothalamus.  PT-141 is also known by its generic name, Bremelanotide, which was originally developed from Melanotan 2. Melanotan 2 was tested as a sunless tanning agent and was proven effective for inducing tanning.  Ironically it was also found to cause arousal and spontaneous erections as unexpected side effects.  Enter PT-141 sold online from United States Peptide Supplier GM2 Labs.

Purchase Pure Peptides Made in America Bremelanotide (PT-141) was developed from Melanotan MT-2. PT-141 is a metabolite of MT-2 that lacks the C-terminal amide function-stripping away tanning properties. PT-141 remains a melanotropic melanocyte stimulating hormone analog, keep in mind while dosing for specific therapy.

Where to Buy PT-141 GM2 Labs sells PT-141 online then delivers to all 50 states in the United States, Canada, Australia, and Europe. Your legal PT-141 without a prescription is sent and delivered to your address once you make your online purchase. Those looking where to buy PT-141 can purchase vials directly from this site.

How PT-141 works? PT141 works on the brain to help trigger arousal. Because it works on the brain, it has proven to improve function in both men and women and it is hoped to be the first sexual enhancement amino acid peptide available for women and not just for men. PT141 has been proven to enhance both sexual desire and function unlike PDE5 blood pushers which only improves function. Men reported PT141 to be more effective with a longer duration of action and more rapid onset time, and better quality libido.

PT-141 vs PDE5: PT-141 is commonly compared to PDE5s due its treatment towards dysfuction in men. PT-141 is also used by women and does not directly effect the vascular system.

Clinical Aphrodisiac As soon as the bremelanotide (a.k.a. PT-141) arrived in the mail, I finally had my hands on the most revolutionary sex drug ever created. This potion had undergone studies for almost a decade in a quest to make it the first-ever FDA-approved aphrodisiac to hit the U.S. market.

Sure, history and folk medicine are full of purported aphrodisiacs, like Spanish fly and rhinoceros horn. But bremelanotide isn't like those - neither is it simply a PDE-5 inhibitors that works by pushing blood around. Bremelanotide belongs to a new class of peptide hormones called melanocortins, which work in the mind, increasing desire. Deep inside the brain, the substance stirs passion by activating hypothalamic and limbic emotional structures, the parts that naturally flare when you're turned on. Scientists aren't exactly sure how melanocortins do this, but the result is clear: Before you know it, you want it. Or at least that's what the research and clinical trial data has shown.

Bremelanotide, originally developed as a safe-tanning agent Melanotan 2, had been repurposed when male study subjects reported a surprising side effect: libido increase. A New Jersey pharmaceutical company purchased the peptide, then turned the pill into a powder that could possibly be delivered nasally, hoping that sleek nasal-spray dispensers could blow away little blue pills - and earn profits dwarfing the $150 million spent on research and clinical testing.

"On the five-point scale, I would rate the erection I had as a six," said one of the 1,300 anonymous Bremelanotide PT-141 testers. "You get this humming feeling," said another. "You're ready to take your pants off and go."

PT-141 worked equally well on women, who chronicled "an intense arousal" that lasted from six to 72 hours. "I was focused on sex," said one women.

But there were side effects, Palatin hit a marketing roadblock just before entering phase-three testing, the FDA's final clinical hurdle before the peptide is released to the public. Some of the men who sniffed bremelanotide experienced an increase in blood pressure, and about one third of the women who took the melanotan research peptide reported nausea. Careful dosage measurement is required for best pt141 aphrodisiac peptide research.

There were also those who doubted PT141 would actually cause couples to want to jump into bed together. "It's baloney," says Leonore Tiefer, a professor of psychiatry at New York University's Langone School of Medicine. "You might increase genital itchiness, but you won't increase desire." It appeared that bremelanotide would fall into the ash heap of failed aphrodisiacs, to rest in peace with tiger penis soup. But then something unexpected happened.

Several hours after dosing PT-141 Bremelanotide, I wasn't experiencing a headache, a palpitating heart, or nausea, but, sadly, I also hadn't enjoyed a spontaneous erection. Then, at four in the morning, it took hold. "I felt a great surge of affection (greater than any regular level of arousal) for my lovely wife. My body tingled and, yes, I developed an erection that wouldn't quit. For two hours the pt141 wouldn't let me out of its grasp - nor my wife out of mine."